A recent clinical genetic study showed that mutations in MYCBP2, the human ortholog of rpm-1, cause a neurodevelopmental spectrum disorder called MDCD [33]. This evidence concerns the gene MYCBP2 and MYCBP2-related developmental delay with corpus callosum defects.